Legend Biotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Legend Biotech (LEGN).

Price Target Range — 12 Quarters

Analyst Consensus — 15 Analysts

11Buy

4Hold

Consensus RatingOverweight# Analysts15Avg. Consensus PT$64Upside to Avg. PT+247.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	Barclays	Etzer Darout	PT Cut	Overweight	$74→$68
Oct 9, 2026	JP Morgan	Jessica Fye	PT Cut	Neutral	$35→$33
Oct 8, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$58→$56
Sep 30, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$65
Sep 11, 2026	Barclays	Etzer Darout	PT Cut	Overweight	$78→$74
Sep 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$65
Aug 12, 2026	Morgan Stanley	Matthew Harrison	PT Raise	Overweight	$48→$49
Aug 12, 2026	TD Cowen	Yaron Werber	PT Cut	Hold	$29→$24
Aug 12, 2026	Oppenheimer	Trevor Allred	Downgrade	Outperform→Perform	$75→$40
Aug 12, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$59→$58
Aug 12, 2026	Barclays	Etzer Darout	PT Cut	Overweight	$80→$78
Jul 28, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$65
Jul 27, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$63→$59
Jul 24, 2026	UBS	Ashwani Verma	Downgrade	Buy→Neutral	$49→$28
Jul 13, 2026	JP Morgan	Jessica Fye	Reinstates	Neutral	$35
Jul 7, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$64→$63
Jun 3, 2026	UBS	Ashwani Verma	PT Raise	Buy	$31→$49
Jun 3, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Raise	Buy	$50→$65
May 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$50
May 13, 2026	TD Cowen	Yaron Werber	PT Raise	Hold	$21→$29